Your browser doesn't support javascript.
loading
Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer.
Shiba-Ishii, Aya; Johnson, Ted W; Dagogo-Jack, Ibiayi; Mino-Kenudson, Mari; Johnson, Theodore R; Wei, Ping; Weinrich, Scott L; McTigue, Michele A; Walcott, Makeba A; Nguyen-Phuong, Linh; Dionne, Kristin; Acker, Adam; Kiedrowski, Lesli A; Do, Andrew; Peterson, Jennifer L; Barth, Jaimie L; Yeap, Beow Y; Gainor, Justin F; Lin, Jessica J; Yoda, Satoshi; Hata, Aaron N.
Afiliação
  • Shiba-Ishii A; Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.
  • Johnson TW; Pfizer Worldwide Research and Development, La Jolla, CA, USA.
  • Dagogo-Jack I; Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.
  • Mino-Kenudson M; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Johnson TR; Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.
  • Wei P; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Weinrich SL; Department of Pathology, Harvard Medical School, Boston, MA, USA.
  • McTigue MA; Pfizer Worldwide Research and Development, La Jolla, CA, USA.
  • Walcott MA; Pfizer Worldwide Research and Development, La Jolla, CA, USA.
  • Nguyen-Phuong L; Pfizer Worldwide Research and Development, La Jolla, CA, USA.
  • Dionne K; Pfizer Worldwide Research and Development, La Jolla, CA, USA.
  • Acker A; Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.
  • Kiedrowski LA; Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.
  • Do A; Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.
  • Peterson JL; Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.
  • Barth JL; Guardant Health, Redwood City, CA, USA.
  • Yeap BY; Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.
  • Gainor JF; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Lin JJ; Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.
  • Yoda S; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Hata AN; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Nat Cancer ; 3(6): 710-722, 2022 06.
Article em En | MEDLINE | ID: mdl-35726063
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article